Osteoclasts from cancer patients were less able to expand NK cells (Supplementary Figure S7A), or increase NK cell-mediated cytotoxicity (Supplementary Figure S7B) or increase NK cell-mediated secretion of IFN-γ (Supplementary Figure S7C) when compared to those from healthy donors. The gene discussed is IFNG; the disease is cancer.